Drug intelligence / Profile preview

SHED

Development stage: Phase 1
Lead developer: Kidswell Bio
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Root Canal

Overview

SHED (Stem cells from human exfoliated deciduous teeth) are multipotent stem cells derived from human exfoliated deciduous teeth. These cells are being investigated for their regenerative potential in various medical conditions. Clinical trials are exploring their use in dental pulp regeneration, treatment of decompensated liver cirrhosis, and Amyotrophic Lateral Sclerosis (ALS), aiming to promote tissue repair, improve neurological function, and slow disease progression.

Other names: Stem cells from human exfoliated deciduous teeth

Beyond the preview

Go deeper on SHED.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SHED.

Explore the full profile